Stanford University
Showing 171-180 of 193 Results
-
Aruna Venkatesan
Clinical Professor (Affiliated), Dermatology
Staff, DermatologyBioAruna Venkatesan, M.D. is Chief of Dermatology and Director of the Genital Dermatology Clinic at Santa Clara Valley Medical Center, a teaching county hospital, and is Clinical Professor of Dermatology (Affiliated) at Stanford. Dr. Venkatesan obtained her MD from the University of California, San Francisco where she was AOA and completed her dermatology residency including a chief resident year at Stanford. Her professional interests include genital skin disease, resident education, primary care provider education, and the use of telemedicine to improve patient care access for vulnerable populations.She has trained with noted vulvovaginal disease experts Dr. Joanna Badger at Stanford and Dr. Libby Edwards. Dr. Venkatesan is a Fellow of the ISSVD and President-Elect for the North American Chapter of the ISSVD.
-
Ricardo Villanueva Gaona
Clinical Rsch Coord 2, Dermatology
Current Role at StanfordClinical Research Coordinator Associate at Dermatology Department
-
Jennifer Y. Wang, MD
Clinical Assistant Professor, Dermatology
BioDr. Wang is a board-certified dermatologist. She is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Wang is also board-certified in dermatopathology.
Her clinical interests include medical dermatology and cutaneous oncology, including melanoma, high-risk skin cancer, and cutaneous lymphoma. Her research interests include the histopathologic characterization of rare skin disorders and improving the detection and treatment of skin cancers. -
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Carl Gustaf Winge,MD PhD
Clinical Instructor, Dermatology
BioMårten Winge, M.D. Ph.D., is a Clinical Instructor of Dermatology and conducts research in the laboratory of Dr Paul Khavari at Stanford, where he studies epidermal differentiation. Dr Winge completed his M.D. and Ph.D studies at Karolinska Institute in Sweden, and subsequently a research fellowship followed by dermatology residency at Stanford. His clinical interests include inflammatory skin disease as well as skin cancer.
